These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 15860385

  • 1. Rapid effect of pravastatin on endothelial function and lipid peroxidation in unstable angina.
    Karatzis E, Lekakis J, Papamichael C, Andreadou I, Cimponeriu A, Aznaouridis K, Papaioannou TG, Protogerou A, Mavrikakis M.
    Int J Cardiol; 2005 May 11; 101(1):65-70. PubMed ID: 15860385
    [Abstract] [Full Text] [Related]

  • 2. Divergent effects of rofecoxib on endothelial function and inflammation in acute coronary syndromes.
    Lekakis JP, Vamvakou G, Andreadou I, Ganiatsos G, Karatzis E, Protogerou A, Papaioannou T, Ikonomidis I, Papamichael C, Mavrikakis ME.
    Int J Cardiol; 2006 Oct 10; 112(3):359-66. PubMed ID: 16330117
    [Abstract] [Full Text] [Related]

  • 3. Rapid effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition on coronary endothelial function.
    Wassmann S, Faul A, Hennen B, Scheller B, Böhm M, Nickenig G.
    Circ Res; 2003 Oct 31; 93(9):e98-103. PubMed ID: 14551237
    [Abstract] [Full Text] [Related]

  • 4. Effects of vitamins C and E on oxidative stress markers and endothelial function in patients with systemic lupus erythematosus: a double blind, placebo controlled pilot study.
    Tam LS, Li EK, Leung VY, Griffith JF, Benzie IF, Lim PL, Whitney B, Lee VW, Lee KK, Thomas GN, Tomlinson B.
    J Rheumatol; 2005 Feb 31; 32(2):275-82. PubMed ID: 15693087
    [Abstract] [Full Text] [Related]

  • 5. Cholesterol lowering is more important than pleiotropic effects of statins for endothelial function in patients with dysglycaemia and coronary artery disease.
    Settergren M, Böhm F, Rydén L, Pernow J.
    Eur Heart J; 2008 Jul 31; 29(14):1753-60. PubMed ID: 18441323
    [Abstract] [Full Text] [Related]

  • 6. Early effects on endothelial function of atorvastatin 40 mg twice daily and its withdrawal.
    Taneva E, Borucki K, Wiens L, Makarova R, Schmidt-Lucke C, Luley C, Westphal S.
    Am J Cardiol; 2006 Apr 01; 97(7):1002-6. PubMed ID: 16563905
    [Abstract] [Full Text] [Related]

  • 7. [Clinical study of pravastatin with different dosage in early admission period in patients with unstable angina].
    Zhao Z, Wu XS, Han ZH, Lü Q, Hu R, Ma CS.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Jan 01; 33(1):54-7. PubMed ID: 15924781
    [Abstract] [Full Text] [Related]

  • 8. Effect of pravastatin compared with placebo initiated within 24 hours of onset of acute myocardial infarction or unstable angina: the Pravastatin in Acute Coronary Treatment (PACT) trial.
    Thompson PL, Meredith I, Amerena J, Campbell TJ, Sloman JG, Harris PJ, Pravastatin in Acute Coronary Treatment (PACT) Investigators.
    Am Heart J; 2004 Jul 01; 148(1):e2. PubMed ID: 15215811
    [Abstract] [Full Text] [Related]

  • 9. A hydroxymethylglutaryl coenzyme A reductase inhibitor improves endothelial function within 7 days in patients with chronic hemodialysis.
    Kishimoto N, Hayashi T, Sakuma I, Kano-Hayashi H, Tsunekawa T, Osawa M, Ina K, Iguchi A.
    Int J Cardiol; 2010 Nov 05; 145(1):21-6. PubMed ID: 19481279
    [Abstract] [Full Text] [Related]

  • 10. Reduction of C-reactive protein with isoflavone supplement reverses endothelial dysfunction in patients with ischaemic stroke.
    Chan YH, Lau KK, Yiu KH, Li SW, Chan HT, Fong DY, Tam S, Lau CP, Tse HF.
    Eur Heart J; 2008 Nov 05; 29(22):2800-7. PubMed ID: 18812325
    [Abstract] [Full Text] [Related]

  • 11. Lipid-independent effects of statins on endothelial function and bioavailability of nitric oxide in hypercholesterolemic patients.
    John S, Schneider MP, Delles C, Jacobi J, Schmieder RE.
    Am Heart J; 2005 Mar 05; 149(3):473. PubMed ID: 15864218
    [Abstract] [Full Text] [Related]

  • 12. Hydroxy-methylglutaryl-coenzyme A reductase inhibition improves endothelial dysfunction in type-1 diabetes.
    Joyce M, Moore K, Thompson C, Fitzgerald P, Fennessy F, Kelly CJ, Bouchier-Hayes DJ.
    Eur J Vasc Endovasc Surg; 2004 Apr 05; 27(4):432-7. PubMed ID: 15015196
    [Abstract] [Full Text] [Related]

  • 13. Effects of atorvastatin on arterial endothelial function in coronary bypass surgery.
    Chello M, Goffredo C, Patti G, Candura D, Melfi R, Mastrobuoni S, Di Sciascio G, Covino E.
    Eur J Cardiothorac Surg; 2005 Dec 05; 28(6):805-10. PubMed ID: 16274999
    [Abstract] [Full Text] [Related]

  • 14. Differential effects of short-term lipid lowering with ezetimibe and statins on endothelial function in patients with CAD: clinical evidence for 'pleiotropic' functions of statin therapy.
    Fichtlscherer S, Schmidt-Lucke C, Bojunga S, Rössig L, Heeschen C, Dimmeler S, Zeiher AM.
    Eur Heart J; 2006 May 05; 27(10):1182-90. PubMed ID: 16621868
    [Abstract] [Full Text] [Related]

  • 15. The effect of simvastatin on erythrocyte membrane fluidity during oxidative stress induced by cardiopulmonary bypass: a randomized controlled study.
    Coccia R, Spadaccio C, Foppoli C, Perluigi M, Covino E, Lusini M, Chello M.
    Clin Ther; 2007 Aug 05; 29(8):1706-17. PubMed ID: 17919551
    [Abstract] [Full Text] [Related]

  • 16. Early and late benefits of high-dose atorvastatin in patients with acute coronary syndromes: results from the PROVE IT-TIMI 22 trial.
    Ray KK, Cannon CP, McCabe CH, Cairns R, Tonkin AM, Sacks FM, Jackson G, Braunwald E, PROVE IT-TIMI 22 Investigators.
    J Am Coll Cardiol; 2005 Oct 18; 46(8):1405-10. PubMed ID: 16226162
    [Abstract] [Full Text] [Related]

  • 17. Effect of intensive lipid-lowering therapy on mortality after acute coronary syndrome (a patient-level analysis of the Aggrastat to Zocor and Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 trials).
    Murphy SA, Cannon CP, Wiviott SD, de Lemos JA, Blazing MA, McCabe CH, Califf RM, Braunwald E.
    Am J Cardiol; 2007 Oct 01; 100(7):1047-51. PubMed ID: 17884359
    [Abstract] [Full Text] [Related]

  • 18. Intense lipid peroxidation in premature clinical coronary atherosclerosis is associated with metabolic abnormalities.
    Fabbi P, Ghigliotti G, Brunelli C, Balbi M, Spallarossa P, Rossettin P, Barsotti A, Odetti P, Garibaldi S.
    J Lab Clin Med; 2004 Feb 01; 143(2):99-105. PubMed ID: 14966465
    [Abstract] [Full Text] [Related]

  • 19. A randomized trial of the effect of statin and fibrate therapy on arterial function in CKD.
    Dogra G, Irish A, Chan D, Watts G.
    Am J Kidney Dis; 2007 Jun 01; 49(6):776-85. PubMed ID: 17533020
    [Abstract] [Full Text] [Related]

  • 20. Effect of losartan, compared with atenolol, on endothelial function and oxidative stress in patients with type 2 diabetes and hypertension.
    Flammer AJ, Hermann F, Wiesli P, Schwegler B, Chenevard R, Hürlimann D, Sudano I, Gay S, Neidhart M, Riesen W, Ruschitzka F, Lüscher TF, Noll G, Lehmann R.
    J Hypertens; 2007 Apr 01; 25(4):785-91. PubMed ID: 17351370
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.